ERNA vs. IB01.L

Last updated Apr 2, 2026

Compare and contrast key facts about Eterna Therapeutics Inc (ERNA) and iShares USD Treasury Bond 0-1yr UCITS ETF (Acc) (IB01.L).

IB01.L is a passively managed fund by iShares that tracks the performance of the Bloomberg US Government TR USD. It was launched on Feb 20, 2019.

Performance

ERNA vs. IB01.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eterna Therapeutics Inc (ERNA) and iShares USD Treasury Bond 0-1yr UCITS ETF (Acc) (IB01.L). The values are adjusted to include any dividend payments, if applicable.

ERNA vs. IB01.L - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ERNA Eterna Therapeutics Inc	-82.46%	-72.79%	-83.62%	-44.25%	-96.14%	-6.92%	1.82%	-37.50%
IB01.L iShares USD Treasury Bond 0-1yr UCITS ETF (Acc)	0.86%	4.34%	5.25%	4.92%	1.08%	0.00%	0.88%	2.01%

Returns By Period

In the year-to-date period, ERNA achieves a -82.46% return, which is significantly lower than IB01.L's 0.86% return.

ERNA

• 1D: 5.78%
• 1M: -24.90%
• YTD: -82.46%
• 6M: -81.54%
• 1Y: -92.41%
• 3Y*: -83.96%
• 5Y*: -82.04%
• 10Y*: -62.85%

IB01.L

• 1D: 0.07%
• 1M: 0.32%
• YTD: 0.86%
• 6M: 1.89%
• 1Y: 4.12%
• 3Y*: 4.75%
• 5Y*: 3.27%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ERNA vs. IB01.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ERNA

ERNA Risk / Return Rank: 5
ERNA Sharpe Ratio Rank: 8
ERNA Sortino Ratio Rank: 1
ERNA Omega Ratio Rank: 2
ERNA Calmar Ratio Rank: 3
ERNA Martin Ratio Rank: 8

IB01.L

IB01.L Risk / Return Rank: 100
IB01.L Sharpe Ratio Rank: 100
IB01.L Sortino Ratio Rank: 100
IB01.L Omega Ratio Rank: 100
IB01.L Calmar Ratio Rank: 100
IB01.L Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ERNA vs. IB01.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eterna Therapeutics Inc (ERNA) and iShares USD Treasury Bond 0-1yr UCITS ETF (Acc) (IB01.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ERNA	IB01.L	Difference
Sharpe ratio Return per unit of total volatility	-0.82	11.48	-12.30
Sortino ratio Return per unit of downside risk	-2.16	30.08	-32.24
Omega ratio Gain probability vs. loss probability	0.73	7.77	-7.04
Calmar ratio Return relative to maximum drawdown	-0.97	47.46	-48.43
Martin ratio Return relative to average drawdown	-1.51	455.81	-457.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ERNA vs. IB01.L - Sharpe Ratio Comparison

The current ERNA Sharpe Ratio is -0.82, which is lower than the IB01.L Sharpe Ratio of 11.48. The chart below compares the historical Sharpe Ratios of ERNA and IB01.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ERNA	IB01.L	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.82	11.48	-12.30
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.65	8.91	-9.56
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.42	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.28	3.73	-4.00

Correlation

The correlation between ERNA and IB01.L is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ERNA vs. IB01.L - Dividend Comparison

Neither ERNA nor IB01.L has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ERNA vs. IB01.L - Drawdown Comparison

The maximum ERNA drawdown since its inception was -100.00%, which is greater than IB01.L's maximum drawdown of -0.91%. Use the drawdown chart below to compare losses from any high point for ERNA and IB01.L.

Drawdown Indicators

	ERNA	IB01.L	Difference
Max Drawdown Largest peak-to-trough decline	-100.00%	-0.91%	-99.09%
Max Drawdown (1Y) Largest decline over 1 year	-94.91%	-0.09%	-94.82%
Max Drawdown (5Y) Largest decline over 5 years	-100.00%	-0.29%	-99.71%
Max Drawdown (10Y) Largest decline over 10 years	-100.00%	—	—
Current Drawdown Current decline from peak	-100.00%	0.00%	-100.00%
Average Drawdown Average peak-to-trough decline	-86.08%	-0.08%	-86.00%
Ulcer Index Depth and duration of drawdowns from previous peaks	61.00%	0.01%	+60.99%

Volatility

ERNA vs. IB01.L - Volatility Comparison

Eterna Therapeutics Inc (ERNA) has a higher volatility of 25.78% compared to iShares USD Treasury Bond 0-1yr UCITS ETF (Acc) (IB01.L) at 0.11%. This indicates that ERNA's price experiences larger fluctuations and is considered to be riskier than IB01.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ERNA	IB01.L	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.78%	0.11%	+25.67%
Volatility (6M) Calculated over the trailing 6-month period	101.70%	0.25%	+101.45%
Volatility (1Y) Calculated over the trailing 1-year period	112.97%	0.36%	+112.61%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	126.06%	0.37%	+125.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	149.49%	0.72%	+148.77%